Alternating PSMA Expression Levels by Ionizing Radiation Exposure as an Additional Feature in PSMA-Targeting Prostate Cancer Treatment: First In Vitro Evaluation

被引:0
|
作者
Arbuznikova, D. [1 ,2 ,3 ]
Boll, M. [1 ,2 ,4 ]
Grosu, A. [3 ,5 ]
Meyer, P. T. [1 ,5 ]
Eder, M. [1 ,2 ,4 ]
Zamboglou, C. [3 ,5 ]
Eder, A. [1 ,2 ,4 ]
机构
[1] Univ Med Ctr Freiburg, Dept Nucl Med, Freiburg, Germany
[2] German Canc Consortium DKTK, Partner Site Freiburg, Div Radiopharmaceut Dev, Freiburg, Germany
[3] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-0195
引用
收藏
页码:S68 / S68
页数:1
相关论文
共 28 条
  • [1] Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
    Murce, Erika
    Beekman, Savanne
    Spaan, Evelien
    Handula, Maryana
    Stuurman, Debra
    de Ridder, Corrina
    Seimbille, Yann
    MOLECULES, 2023, 28 (10):
  • [2] Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer
    Murce, Erika
    Spaan, Evelien
    Seimbille, Yann
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S206 - S207
  • [3] Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
    Ng, Thomas S. C.
    Gao, Xin
    Salari, Keyan
    Zlatev, Dimitar V.
    Heidari, Pedram
    Kamran, Sophia C.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Multimeric PSMA-targeting small molecule thorium-227 conjugates for the treatment of prostate cancer
    Papple, A.
    Indrevoll, B.
    Hammer, S.
    Kristian, A.
    Mumberg, D.
    Cuthbertson, A.
    Zitzmann-Kolbe, S.
    Boehnke, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S438 - S438
  • [5] Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
    Ruigrok, Eline A. M.
    Verkaik, Nicole S.
    de Blois, Erik
    de Ridder, Corrina
    Stuurman, Debra
    Roobol, Stefan J.
    Van Gent, Dik C.
    de Jong, Marion
    Van Weerden, Wytske M.
    Nonnekens, Julie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [6] Development of a novel PSMA-targeting small molecule-Thorium-227 conjugate for the treatment of prostate cancer
    Boehnke, Niels
    Indrevoll, Bard
    Hammer, Stefanie
    Papple, Alex
    Kristian, Alexander
    Cuthbertson, Alan
    Zitzmann-Kolbe, Sabine
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Re: 225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
    Hadaschik, Boris
    EUROPEAN UROLOGY, 2016, 70 (06) : 1080 - 1081
  • [8] Evaluation of a Long-circulating PSMA-targeting Peptide in a Xenograft Model of Bone Metastatic Prostate Cancer.
    Lo, W.
    Huang, Y.
    Chen, M.
    Lu, A.
    Wang, S.
    Chen, L.
    Farn, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S442 - S442
  • [9] Synthesis, radiolabelling and in vitro characterisation of a bimodal BODIPY-labelled PSMA-targeting bioconjugate for dual imaging of prostate cancer
    Stemler, T.
    Hierlmeier, I.
    Maus, S.
    Rosar, F.
    Khreish, F.
    Ezziddin, S.
    Krause, E.
    Hoffmann, C.
    Jung, G.
    Bartholomae, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S21 - S21
  • [10] Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography
    Lu, Kelly
    Zhang, Chengcheng
    Zhang, Zhengxing
    Merkens, Helen
    Wilson, Ryan
    Colpo, Nadine
    Benard, Francois
    Lin, Kuo-Shyan
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S86 - S87